INDIGO - Internet-administered Interpersonal Psychotherapy for Depressive Symptoms
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Major Depressive Disorder
- Sponsor
- Linkoeping University
- Enrollment
- 113
- Locations
- 1
- Primary Endpoint
- Change on Montgomery Åsberg Depression Rating Scale (MADRS-S)
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The aim of the study is to test the efficacy of a treatment for depression based on interpersonal psychotherapy (IPT). The treatment will be accessed via an internet platform built for this study. A therapist will provide support weekly, as well as on-demand when needed. The treatment lasts for 10 weeks.
Investigators
Gerhard Andersson
Professor
Linkoeping University
Eligibility Criteria
Inclusion Criteria
- •A diagnosis of Major depressive disorder (as indicated by the MINI 7.0 Neuropsychiatric interview) and/or depressive symptoms equal to or more severe than mild depression on the MADRS-S (equal to or above 13 points) and/or BDI (equal to or above 14 points).
- •Age of at least 18 years old.
- •Adequate ability to speak, write, and read Swedish.
- •Internet access for the duration of the study.
Exclusion Criteria
- •Ongoing substance abuse.
- •Suicidal plans.
- •A diagnosed personality syndrome (as diagnosed before the study by a licensed psychiatric healthcare professional).
- •Other ongoing psychological treatment.
- •Other severe psychiatric comorbidity that requires specialized care (e.g. anorexia nervosa, psychosis).
- •Recent changes in psychotropic medication or planned changes during the initial treatment period.
Outcomes
Primary Outcomes
Change on Montgomery Åsberg Depression Rating Scale (MADRS-S)
Time Frame: Before the treatment, during week 1 to 10 of the treatment, after 11 weeks. Follow-up one year after the start of the treatment.
Depression inventory, consists of 9 items measuring symptoms of major depressive disorder. Each item are scored between 0 and 6 points, resulting in a total sum between 0 and 54. Cut-offs are: 0-12 No substantial depressive symptoms, 13-19 mild depressive symptoms, 20-34 moderate depressive symptoms, 35-54 severe depressive symptoms.
Secondary Outcomes
- Change on Brunnsviken Brief Quality of Life Inventory (BBQ)(Before treatment and after 11 weeks, follow-up one year after the start of the treatment.)
- Change on Generalized Anxiety Disorder 7-Item Scale (GAD-7)(Before treatment and after 11 weeks, follow-up one year after the start of the treatment.)
- Change on Reflective Functioning Questionnaire-8 item version (RFQ-8)(Before treatment, after 11 weeks, following one year after the start of the treatment.)
- Change on Beck Depression Inventory-II (BDI-II)(Before treatment and after 11 weeks, follow-up one year after the start of the treatment.)